Concepedia

Publication | Open Access

CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis

DOIFull Paper Access

36

Citations

38

References

2022

Year

Jing Wu, Zhijun Zhou, Jin Li, Huifang Liu, Huaqi Zhang, Junchang Zhang, Weibin Huang, Yulong He, Shiyu Zhu, Mingyu Huo,
Drug Resistance Updates

Abstract

This study identifies CHD4 dominated multi-drug efflux as a promising therapeutic target for overcoming acquired chemoresistance in GC.

References

YearCitations

Page 1